All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
SUMMIT THERAPEUTICS INC. Last Reported: 5/31/2024 Stock Symbol: SMMT

Business Address

2882 SAND HILL ROAD
SUITE 106
MENLO PARK , CA US 94025

Mailing Address

2882 SAND HILL ROAD
SUITE 106
MENLO PARK , CA US 94025
Phone Number: 650-460-8308 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 11/30/2022 7/31/2022 6/30/2022 3/31/2022 12/31/2021 6/30/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 1/31/2019 12/31/2018 1/31/2018 1/31/2017
Cash and Cash Equivalents $61,294,000.00 $71,425,000.00 $23,792,000.00 $42,116,000.00 $70,969,000.00 $348,607,000.00 -- -- -- -- -- $103,400,000.00 $66,417,000.00 -- $21,300,000.00 $36,400,000.00 -- $63,842,000.00 -- -- -- $35,245,000.00 -- $28,495,000.00 --
Accounts Receivable Net Current -- -- -- -- -- $349,000.00 -- -- $238,000.00 $870,000.00 $1,464,000.00 $1,053,000.00 $331,000.00 -- $4,080,000.00 $464,000.00 -- $541,000.00 -- -- -- $6,120,000.00 -- $3,899,000.00 --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $5,323,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $163,265,000.00 $189,712,000.00 $204,951,000.00 $227,501,000.00 $248,027,000.00 $656,712,000.00 -- -- $79,398,000.00 $99,435,000.00 $97,312,000.00 $121,482,000.00 $87,674,000.00 -- $42,077,000.00 $55,552,000.00 -- $79,628,000.00 -- -- -- $61,254,000.00 -- $50,809,000.00 --
Property Plant and Equipement $181,000.00 $204,000.00 $229,000.00 $225,000.00 $412,000.00 $906,000.00 -- -- $1,095,000.00 $965,000.00 $694,000.00 $757,000.00 $725,000.00 -- $724,000.00 $562,000.00 -- $518,000.00 -- -- -- $649,000.00 -- $953,000.00 --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill $1,875,000.00 $1,893,000.00 $1,814,000.00 $1,883,000.00 $1,839,000.00 $1,798,000.00 -- -- $1,806,000.00 $1,953,000.00 $2,009,000.00 $2,057,000.00 $2,030,000.00 -- $2,335,000.00 $2,236,000.00 -- $1,961,000.00 -- -- -- $1,951,000.00 -- $3,513,000.00 $836,000.00
Other Assets $1,875,000.00 $4,322,000.00 $4,332,000.00 $254,000.00 $156,000.00 $577,000.00 -- -- $179,000.00 $166,000.00 $170,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $176,781,000.00 $202,949,000.00 $218,476,000.00 $237,372,000.00 $254,897,000.00 $664,168,000.00 -- -- $95,718,000.00 $116,472,000.00 $113,374,000.00 $145,517,000.00 $102,498,000.00 -- $56,865,000.00 $70,949,000.00 -- $96,679,000.00 -- -- -- $79,570,000.00 -- $78,210,000.00 --
Accounts Payable $6,371,000.00 $2,667,000.00 $3,314,000.00 $987,000.00 $710,000.00 $355,000.00 -- -- $3,574,000.00 $6,959,000.00 $4,374,000.00 $6,949,000.00 $6,140,000.00 -- $2,493,000.00 $3,091,000.00 -- $4,471,000.00 -- -- -- $5,803,000.00 -- $6,257,000.00 --
Accrued Liabilities $6,547,000.00 $8,783,000.00 $3,654,000.00 $3,868,000.00 $12,304,000.00 $10,664,000.00 -- -- $5,513,000.00 $7,569,000.00 $7,197,000.00 $6,132,000.00 $4,261,000.00 -- $4,398,000.00 $4,518,000.00 -- $5,739,000.00 -- -- -- $5,200,000.00 -- $5,971,000.00 --
Total Current Liabilities $132,571,000.00 $125,257,000.00 $119,097,000.00 $117,773,000.00 $121,415,000.00 $537,514,000.00 -- -- $44,401,000.00 $52,065,000.00 $30,090,000.00 $26,090,000.00 $23,045,000.00 -- $20,004,000.00 $19,003,000.00 -- $17,385,000.00 -- -- -- $23,750,000.00 -- $82,673,000.00 --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-2,449,000.00 $-2,448,000.00 $-2,323,000.00 $-2,437,000.00 $-1,396,000.00 $-1,893,000.00 -- -- $-3,168,000.00 $-3,957,000.00 $-2,197,000.00 $-2,579,000.00 $-3,794,000.00 -- $-7,032,000.00 $-9,287,000.00 -- $-4,720,000.00 -- -- -- $-4,767,000.00 -- $-4,347,000.00 --
Accumulated Deficit $-1,036,731,000.00 $-993,258,000.00 $-956,691,000.00 $-935,423,000.00 $-920,706,000.00 $-378,330,000.00 -- -- $-337,716,000.00 $-320,945,000.00 $-299,548,000.00 $-252,900,000.00 $-210,900,000.00 -- $-199,200,000.00 $-181,473,000.00 -- $-159,919,000.00 -- -- -- $-130,939,000.00 -- $-140,837,000.00 --
Total Stockholders' Equity $44,210,000.00 $77,692,000.00 $99,379,000.00 $119,599,000.00 $133,482,000.00 $126,654,000.00 -- -- $51,317,000.00 $64,407,000.00 $83,284,000.00 $119,427,000.00 $79,453,000.00 -- $36,861,000.00 $51,946,000.00 $66,692,000.00 $78,863,000.00 $36,177,000.00 $43,564,000.00 $51,236,000.00 $55,820,000.00 $32,170,000.00 $-3,589,000.00 $-4,398,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $176,781,000.00 $202,949,000.00 $218,476,000.00 $237,372,000.00 $254,897,000.00 $664,168,000.00 -- -- $95,718,000.00 $116,472,000.00 $113,374,000.00 $145,517,000.00 $102,498,000.00 -- $56,865,000.00 $70,949,000.00 -- $96,679,000.00 -- -- -- $79,570,000.00 -- $78,210,000.00 --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 11/30/2022 7/31/2022 6/30/2022 3/31/2022 12/31/2021 6/30/2021 12/31/2020 10/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 1/31/2019 12/31/2018 1/31/2018 1/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $30,873,000.00 $59,471,000.00 $34,657,000.00 $19,334,000.00 $9,883,000.00 $51,999,000.00 -- -- $9,008,000.00 $20,556,000.00 $85,352,000.00 $42,302,000.00 $53,274,000.00 -- $40,979,000.00 $26,592,000.00 -- $39,809,000.00 $9,951,000.00 $22,635,000.00 -- $52,003,000.00 -- $37,722,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $42,602,000.00 $610,651,000.00 $20,757,000.00 $553,505,000.00 $537,738,000.00 $87,210,000.00 -- -- $15,941,000.00 $27,215,000.00 $108,963,000.00 $52,471,000.00 $73,365,000.00 -- $55,268,000.00 $19,404,000.00 -- $51,088,000.00 $40,503,000.00 $27,869,000.00 -- $73,693,000.00 -- $53,385,000.00 --
Loss from Operations $-42,389,000.00 $-609,650,000.00 $-573,440,000.00 $-552,948,000.00 $-537,154,000.00 $-72,089,000.00 -- -- $-34,850,000.00 $-22,158,000.00 $-86,186,000.00 $-40,653,000.00 $-53,193,000.00 -- $-18,216,000.00 $-21,428,000.00 -- $-28,805,000.00 $-6,190,000.00 $-6,743,000.00 -- $5,389,000.00 -- $-28,367,000.00 --
Loss Before Income Taxes -- $-614,928,000.00 -- -- -- $-78,782,000.00 -- -- -- -- $-88,602,000.00 $-41,904,000.00 $-52,910,000.00 -- $-39,348,000.00 $-15,422,000.00 -- $-29,091,000.00 $-6,265,000.00 $-6,822,000.00 -- $9,083,000.00 -- $-25,882,000.00 --
Earnings Per Share Basic $-0.06 $-0.99 $-0.98 $-0.02 $-1.43 $-0.41 -- -- $-0.17 $-0.22 $-0.96 $-0.48 $-0.76 -- $-0.26 $-0.23 -- $-0.89 $-0.20 $-0.44 -- $0.63 -- $-2.01 --
Weighted Average Shares Basic 701,785,250 619,646,180 592,366,880 697,685,365 378,163,980 193,336,063 -- -- 99,627,701 98,070,095 92,239,306 86,755,983 69,524,000 -- 67,232,000 67,225,000 -- 32,829,000 32,099,000 31,395,000 -- 17,140,000 -- 13,087,000 --
Earnings Per Share Diluted $-0.06 $-0.99 $-0.03 $-1.03 $-1.43 $-0.41 -- -- $-0.17 $-0.22 $-0.96 $-0.48 $-0.76 -- $-0.58 $-0.32 -- $-0.88 $-0.63 $-0.44 -- $0.57 -- $-2.01 --
Weighted Average Shares Diluted 701,785,250 619,646,180 697,739,477 538,807,328 378,163,980 193,336,063 -- -- 99,654,092 98,070,095 92,239,306 86,755,983 69,524,148 -- 67,232,000 67,232,000 -- 32,829,000 31,632,000 31,395,000 -- 17,228,718 -- 13,087,000 --
Common Stock Shares Authorized 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 1,000,000,000 350,000,000 -- 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 250,000,000 -- 250,000,000 250,000,000 -- 250,000,000 -- -- -- 250,000,000 -- 250,000,000 --
Common Stock Shares Outstanding 701,974,596 701,660,053 697,851,308 697,685,365 697,685,365 211,091,425 -- -- 98,122,356 98,122,356 98,039,540 97,351,799 82,575,064 -- 67,231,903 67,231,900 -- 67,178,054 -- -- -- 32,077,974 -- 14,712,724 --
Common Stock Value $7,020,000.00 $7,017,000.00 $6,978,000.00 $6,976,000.00 $6,976,000.00 $2,110,000.00 -- -- $981,000.00 $981,000.00 $980,000.00 $974,000.00 $826,000.00 -- $672,000.00 $672,000.00 -- $672,000.00 -- -- -- $321,000.00 -- $147,000.00 --
Common Stock Par Or Stated Value Per Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 -- $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 -- $0.01 -- -- -- $0.01 -- $0.01 --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 20,000,000 20,000,000 20,000,000 20,000,000 20,000,000 20,000,000 -- -- 20,000,000 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 -- -- $0.01 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- $1.06 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com